G Favez, R Chioléro, C Willa. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAgedDrug Resistance, MicrobialFemaleFollow-Up StudiesHumansIsoniazid/administration & dosageIsoniazid/adverse effectsIsoniazid/therapeutic useLiver Function TestsMaleMiddle AgedMycobacterium tuberculosis/isolation & purificationRifampin/administration & dosageRifampin/adverse effectsRifampin/therapeutic useSputum/microbiologyStreptomycin/administration & dosageStreptomycin/adverse effectsStreptomycin/therapeutic useTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiology
Substances: See more » IsoniazidRifampinStreptomycin
Year: 1972 PMID: 4624280 DOI: 10.1378/chest.61.6_supplement.583
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410